J. V. Dzhinibalaeva

J. V. Dzhinibalaeva

Auto-generated profile, based on publicly available information

J. V. Dzhinibalaeva

Samara State Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
DGD. A. Grabovyi
D. A. Grabovyi
JDJ. V. Dzhinibalaeva
J. V. Dzhinibalaeva
EAE. V. Adonina
E. V. Adonina
Dmitry V. DuplyakovDmitry V. Duplyakov
Dmitry V. Duplyakov
Takayasu's arteritis is a chronic granulomatous vasculitis of large vessels of unclear etiology, predominantly affecting the aorta and its main branches, with possible involvement of the coronary and pulmonary arteries. The true prevalence of this disease is unknown, but it is extremely low, given the rare diagnosis and the absence of pathognomonic symptoms. In clinical practice, the criteria proposed by the American College of Rheumatology are used for making a diagnosis. A wide range of imaging diagnostic techniques plays a significant role. This article provides a literature review and a case report of Takayasu's arteritis in a patient admitted with an acute coronary syndrome.

6 May 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
AGAndrey Garanin
Andrey Garanin
ARAnatoly Rubanenko
Anatoly Rubanenko
ЮТЮрий Александрович Трусов
Юрий Александрович Трусов
OROlesya Rubanenko
Olesya Rubanenko
JDJ. V. Djinibalaeva
J. V. Djinibalaeva
ЖДЖ. В. Джинибалаева
Ж. В. Джинибалаева
Aim. To study the literature data and evaluate the telemonitoring results in patients with heart failure to determine their impact on the quality of life.Material and methods. We searched information according to PRISMA require­ments using the following databases: PubMed, Embase, Crossref, MedLine, Clinical Trials and e-Library. Ten randomized controlled trials were selected for the final analysis of full-text articles. In these studies, the quality of life was analyzed using the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and EuroQol-5 Dimension (EQ-5D Utilities and EQ-5D VAS) questionnaire.Results. Among 285 patients with telemonitoring and 294 patients with standard management, MLHFQ did not reveal statistical significance (mean difference -0,75, -7,08-5,58, I2=97%, p=0,82). Similar results were obtained for the EuroQol-5 Dimension (EQ-5D VAS — mean difference 2,76, -1,23-6,74, I2=44%, p=0,18) and EQ-5D Utilities (mean difference 0,00, -0,05-0,05, I2=0%, p=1,00) questionnaires.Conclusion. The current systematic review and meta-analysis showed that the use of telemedicine technologies in patients with heart failure does not affect the quality of life of patients.